. 2008 Jun 27;466(9):2217–2223. doi: 10.1007/s11999-008-0356-7

Table 2.

Comparison of published outcomes for sacral chordomas

Authors	Patients	Followup	LR	LR with wide margins	LR with inadequate margins	Death rate (disease related)
Bergh et al. [4]	30	8.1 years (0.2–23)	12	6/16	6/14	10
Bergh et al. [4]	30	8.1 years (0.2–23)	30%	37%	43%	33%
Yonemoto et al. [31]	13	6.3 years (0.5–13.7)	6	0/3	6/10	7
Yonemoto et al. [31]	13	6.3 years (0.5–13.7)	46%	0%	60%	54%
Baratti et al. [3]	28	5.9 years (1.2–16.6)	17	6/11	11/17	10
Baratti et al. [3]	28	5.9 years (1.2–16.6)	61%	54%	65%	36%
York et al. [32]	27	3.6 years (0.3–34)	18	8/15	10/12	15
York et al. [32]	27	3.6 years (0.3–34)	66%	53%	83%	55%
Hulen et al. [18]	16	5.5 years (1.2–14.5)	12	9/16	7/16	6
Hulen et al. [18]	16	5.5 years (1.2–14.5)	75%	56%	44%	37%
Fuchs et al. [15]	52	7.8 years (2.1–23)	23	1/21	22/31	19
Fuchs et al. [15]	52	7.8 years (2.1–23)	44%	5%	71%	36%
Current study	18	4.4 years (0.5–10)	12	6/10	6/8	7
Current study	18	4.4 years (0.5–10)	66%	60%	75%	39%

LR = local recurrence.